(ICL) ICL Israel Chemicals - Ratings and Ratios
Exchange: NYSE • Country: Israel • Currency: USD • Type: Common Stock • ISIN: IL0002810146
ICL EPS (Earnings per Share)
ICL Revenue
ICL: Potash, Phosphate, Bromine, Magnesium, Fertilizers
ICL Group Ltd is a global specialty minerals and chemicals company that operates through four distinct business segments: Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. The company produces a diverse range of products, including bromine-based compounds, potash, phosphate-based fertilizers, and specialty fertilizers, serving various industries such as agriculture, pharmaceuticals, and electronics.
The Industrial Products segment leverages the by-products of potash production to manufacture bromine and bromine-based compounds, while also producing phosphorous-based flame retardants. The Potash segment is a significant producer of potash, salt, and magnesium, with related by-products like chlorine and sylvinite. Meanwhile, the Phosphate Solutions segment focuses on producing specialty phosphate products, including fertilizers and phosphate salts. The Growing Solutions segment develops and markets a range of fertilizers and agricultural products, including water-soluble and controlled-release fertilizers.
ICLs product portfolio is diversified across multiple industries, including agriculture, pharmaceuticals, electronics, and construction. The companys digital platforms and technological solutions for farmers and agronomists also demonstrate its commitment to innovation. With a global presence, ICL sells its products through various marketing channels, including marketing companies, agents, and distributors.
Analyzing the technical data, ICLs stock price is currently at $6.72, with a 20-day SMA of $6.64 and a 50-day SMA of $6.38, indicating a positive trend. The 200-day SMA is $5.24, suggesting a significant uptrend over the past year. The ATR is 0.14, representing a 2.07% daily volatility. The stock is currently trading near its 52-week high of $6.98, with a low of $3.67.
From a fundamental perspective, ICL has a market capitalization of $8.53 billion and a P/E ratio of 21.32, indicating a relatively stable valuation. The Return on Equity (RoE) is 6.71%, suggesting a decent level of profitability. Considering the technical and fundamental data, a forecast for ICL could be that the stock will continue its upward trend, potentially reaching $7.50 in the next 6-12 months, driven by the companys diversified product portfolio, global presence, and innovation in the agricultural and industrial sectors.
Based on the analysis, ICLs strengths include its diversified business segments, global presence, and commitment to innovation. However, the company may face challenges related to commodity price volatility, regulatory changes, and competition in the agricultural and industrial sectors. To mitigate these risks, ICL may need to continue to innovate and adapt to changing market conditions.
Additional Sources for ICL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
ICL Stock Overview
Market Cap in USD | 8,625m |
Sector | Basic Materials |
Industry | Agricultural Inputs |
GiC Sub-Industry | Fertilizers & Agricultural Chemicals |
IPO / Inception | 2014-09-24 |
ICL Stock Ratings
Growth Rating | 54.7 |
Fundamental | -4.97 |
Dividend Rating | 56.1 |
Rel. Strength | 66.4 |
Analysts | 3 of 5 |
Fair Price Momentum | 7.17 USD |
Fair Price DCF | 5.22 USD |
ICL Dividends
Dividend Yield 12m | 3.14% |
Yield on Cost 5y | 8.71% |
Annual Growth 5y | 16.33% |
Payout Consistency | 67.0% |
Payout Ratio | 48.8% |
ICL Growth Ratios
Growth Correlation 3m | 58.5% |
Growth Correlation 12m | 90% |
Growth Correlation 5y | 10.7% |
CAGR 5y | 26.41% |
CAGR/Max DD 5y | 0.42 |
Sharpe Ratio 12m | 0.99 |
Alpha | 52.52 |
Beta | 0.912 |
Volatility | 32.69% |
Current Volume | 494.8k |
Average Volume 20d | 748.4k |
As of July 01, 2025, the stock is trading at USD 6.88 with a total of 494,821 shares traded.
Over the past week, the price has changed by +1.78%, over one month by +3.67%, over three months by +21.71% and over the past year by +71.32%.
Neither. Based on ValueRay´s Fundamental Analyses, ICL Israel Chemicals is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -4.97 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ICL is around 7.17 USD . This means that ICL is currently overvalued and has a potential downside of 4.22%.
ICL Israel Chemicals has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold ICL.
- Strong Buy: 0
- Buy: 0
- Hold: 4
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, ICL ICL Israel Chemicals will be worth about 8.1 in July 2026. The stock is currently trading at 6.88. This means that the stock has a potential upside of +18.17%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 6.6 | -4.4% |
Analysts Target Price | 6.6 | -4.4% |
ValueRay Target Price | 8.1 | 18.2% |